california semaglutide compounding pharmacy Compound – Alliant LTC FDA warns about compounded versions

October 15, 2025: State Lawsuits Accuse Eli Lilly of Downplaying Trulicity Side Effects About 40 lawsuits filed in Indiana accuse Eli Lilly of downplaying the risks of its GLP-1 drugs, like Trulicity

The ozempic segment dominated the market in 2025 with 32.15% share

In a trial of semaglutide injection (Wegovy) in patients with T2DM and BMI of 27 kg/m2 or more, diabetic retinopathy was reported by 4% of semaglutide-treated patients vs

Soon after developing GLP-1s, researchers uncovered a second therapeutic effect that could benefit an even larger patient population: sustainable, clinically meaningful weight loss

Do gut hormones contribute to weight loss and glycaemic outcomes after bariatric surgery